HBT
TEVA icon

Hills Bank & Trust’s Teva Pharmaceuticals TEVA Stock Holding History

Hills Bank & Trust’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-15,571
Closed -$565K – 128
2016
Q4 		$565K Sell
15,571
-25,870
-62% -$1.03M 0.2% 87
2016
Q3 		$1.91M Sell
41,441
-6,668
-14% -$348K 0.69% 33
2016
Q2 		$2.42M Sell
48,109
-1,153
-2% -$61.4K 0.89% 30
2016
Q1 		$2.64M Sell
49,262
-4,987
-9% -$293K 0.97% 28
2015
Q4 		$3.56M Sell
54,249
-571
-1% -$35.3K 1.35% 21
2015
Q3 		$3.1M Sell
54,820
-535
-1% -$34.7K 1.22% 25
2015
Q2 		$3.27M Buy
55,355
+850
+2% +$52.4K 1.21% 25
2015
Q1 		$3.4M Buy
54,505
+3,794
+7% +$221K 1.27% 23
2014
Q4 		$2.92M Sell
50,711
-910
-2% -$50.7K 1.15% 28
2014
Q3 		$2.77M Sell
51,621
-135
-0.3% -$7.15K 1.13% 26
2014
Q2 		$2.71M Buy
51,756
+48
+0.1% +$2.45K 1.13% 26
2014
Q1 		$2.73M Sell
51,708
-275
-0.5% -$12.7K 1.17% 24
2013
Q4 		$2.08M Buy
51,983
+299
+0.6% +$11.8K 0.92% 34
2013
Q3 		$1.95M Buy
51,684
+435
+0.8% +$17K 0.95% 33
2013
Q2 		$2.01M Buy
+51,249
New +$2M 1.05% 30

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Hills Bank & Trust's TEVA Position: Q1 2017 in Review

Hills Bank & Trust sold out of Teva Pharmaceuticals (TEVA) in Q1 2017, closing a stake of 15,571 shares — an estimated $565K sold.

Hills Bank & Trust first reported a position in TEVA in Q2 2013 and held it in 15 quarters. The position peaked at $3.56M in Q4 2015. 686 funds tracked by Wall St. Rank hold TEVA as of Q1 2017.

  • Hills Bank & Trust reported no remaining Teva Pharmaceuticals position as of Q1 2017 after selling out during the quarter.
  • Hills Bank & Trust sold 15,571 Teva Pharmaceuticals shares in Q1 2017, an estimated $565K.
  • Hills Bank & Trust first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 15 quarters.
  • Hills Bank & Trust's Teva Pharmaceuticals position peaked at $3.56M in Q4 2015.
  • 686 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2017.

Based on Hills Bank & Trust's 13F filing for Q1 2017, filed 6 Apr 2017.